SNDL (SNDL) Competitors $1.42 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.42 0.00 (-0.35%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNDL vs. ACB, CGC, CRON, OGI, TLRY, TVTX, CVAC, PAHC, ABCL, and CALTShould you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), Tilray Brands (TLRY), Travere Therapeutics (TVTX), CureVac (CVAC), Phibro Animal Health (PAHC), AbCellera Biologics (ABCL), and Calliditas Therapeutics AB (publ) (CALT). These companies are all part of the "pharmaceutical products" industry. SNDL vs. Its Competitors Aurora Cannabis Canopy Growth Cronos Group Organigram Global Tilray Brands Travere Therapeutics CureVac Phibro Animal Health AbCellera Biologics Calliditas Therapeutics AB (publ) Aurora Cannabis (NASDAQ:ACB) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations. Do institutionals and insiders hold more shares of ACB or SNDL? 47.6% of Aurora Cannabis shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, ACB or SNDL? Aurora Cannabis has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, SNDL has a beta of 3.4, indicating that its stock price is 240% more volatile than the S&P 500. Do analysts prefer ACB or SNDL? SNDL has a consensus price target of $3.63, suggesting a potential upside of 155.28%. Given SNDL's higher probable upside, analysts clearly believe SNDL is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67SNDL 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to ACB or SNDL? In the previous week, SNDL had 2 more articles in the media than Aurora Cannabis. MarketBeat recorded 5 mentions for SNDL and 3 mentions for Aurora Cannabis. SNDL's average media sentiment score of 0.53 beat Aurora Cannabis' score of 0.33 indicating that SNDL is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SNDL 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ACB or SNDL more profitable? Aurora Cannabis has a net margin of 1.32% compared to SNDL's net margin of -11.48%. Aurora Cannabis' return on equity of 0.13% beat SNDL's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis1.32% 0.13% 0.10% SNDL -11.48%-9.02%-7.60% Which has higher valuation and earnings, ACB or SNDL? Aurora Cannabis has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$246.72M1.07$1.63M$0.1142.64SNDL$671.81M0.56-$69.18M-$0.29-4.90 SummaryAurora Cannabis beats SNDL on 11 of the 16 factors compared between the two stocks. Get SNDL News Delivered to You Automatically Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNDL vs. The Competition Export to ExcelMetricSNDLMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$373.14M$10.57B$5.56B$9.04BDividend YieldN/A2.08%5.25%4.03%P/E Ratio-4.9016.5627.1820.14Price / Sales0.5630.26440.78137.14Price / CashN/A22.8437.5058.41Price / Book0.453.758.085.60Net Income-$69.18M$235.43M$3.16B$248.43M7 Day Performance11.37%3.78%3.77%5.15%1 Month Performance7.58%3.95%3.90%7.62%1 Year Performance-30.39%-9.49%34.22%21.56% SNDL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNDLSNDL3.6638 of 5 stars$1.42flat$3.63+155.3%-27.9%$373.14M$671.81M-4.902,516News CoverageGap DownACBAurora Cannabis0.3488 of 5 stars$4.43-2.4%N/A-14.6%$249.01M$246.72M40.271,130CGCCanopy Growth0.8042 of 5 stars$1.20-6.3%$2.00+66.7%-79.6%$220.64M$225.65M-0.303,150News CoverageCRONCronos Group2.2936 of 5 stars$2.04flatN/A-7.1%$786.79M$117.61M15.69450News CoverageOGIOrganigram Global0.9872 of 5 stars$1.39-2.8%N/A-8.3%$186.18M$117.47M13.90860News CoverageTLRYTilray Brands2.2037 of 5 stars$0.50-6.6%$1.92+280.7%-61.6%$506.67M$788.94M-0.482,650News CoverageTVTXTravere Therapeutics3.2115 of 5 stars$14.60-2.7%$32.14+120.2%+72.1%$1.30B$273.53M-5.20460CVACCureVac4.7316 of 5 stars$5.41-0.7%$6.83+26.3%+79.7%$1.21B$523.70M5.88880PAHCPhibro Animal Health3.7136 of 5 stars$29.90+6.8%$24.40-18.4%+83.1%$1.21B$1.02B38.331,940Analyst UpgradeHigh Trading VolumeABCLAbCellera Biologics2.5685 of 5 stars$4.03+6.1%$7.50+86.1%+49.6%$1.20B$28.83M-7.20500News CoverageAnalyst ForecastAnalyst RevisionHigh Trading VolumeCALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180 Related Companies and Tools Related Companies Aurora Cannabis Alternatives Canopy Growth Alternatives Cronos Group Alternatives Organigram Global Alternatives Tilray Brands Alternatives Travere Therapeutics Alternatives CureVac Alternatives Phibro Animal Health Alternatives AbCellera Biologics Alternatives Calliditas Therapeutics AB (publ) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNDL) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SNDL Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SNDL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNDL Stock Alerts